Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma.

While promising results from phase II studies are infrequently reproduced in phase III studies in other cancers, 6 , 43 our study found phase II and phase III GBM studies that were optimally matched had an excellent and highly significant concordance for both OS and PFS.

also in 132,142 other papers